Seeking Alpha

Sequenom, Inc (SQNM) summarizes their mission as improving healthcare through revolutionary genetic analysis solutions. They operate in two business segments: Diagnostic Services and Genetic Analysis. Driving my investment thesis in Sequenom is the disruptive innovation occurring in genomic personalized medicine, which is revolutionizing the healthcare industry at a breathtaking pace. Nowhere is this more visible than in the nascent Noninvasive Prenatal Testing ("NIPT") market, in which Sequenom and a few other companies are quite literally changing prenatal care at an unprecedented rate. That these fundamental shifts are occurring so rapidly has compounded existing investor uncertainty caused by a lack of financial visibility. It is my contention that these clouds are beginning to dissipate,...

Only subscribers can access this article, which is part of the PRO research library covering 3,770 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: